<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39469684</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>30</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Cognitive outcomes and psychological symptoms in an Italian cohort with post-acute COVID-19 condition (PACC).</ArticleTitle><Pagination><StartPage>e39431</StartPage><MedlinePgn>e39431</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39431</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2024.e39431</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">We aim to investigate the proportion of patients (pts) with long-term cognitive outcomes (CO) of PACC and identify associated features.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We assessed participants through a neuropsychological assessment. The chi-square test was used for comparisons according with time of NPA (within or beyond 6 months since COVID19) and with previously hospitalization status (hospitalized patients, PH; not hospitalized patients, nPH).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">520&#xa0;participants: mean age 54 years (SD 12), 53&#xa0;% female, 14 years of education (SD 3.4), 35&#xa0;% with &gt;1 comorbidity, 48&#xa0;% previously hospitalized. Overall, we found CO in 89&#xa0;% of pts, in particular 88&#xa0;% evaluated in w6M and 89&#xa0;% in b6M (p&#xa0;=&#xa0;0.801) while 90&#xa0;% and 87&#xa0;% in nPH and PH, respectively (p&#xa0;=&#xa0;0.239). By fitting multivariable analysis, PH for COVID19 and female gender were associated with an increased risk of an altered PSQI [Odd Ratio, OR 2.48, 95&#xa0;% CI 1.54 to 3.99, p&#xa0;&lt;&#xa0;0.001 and OR 2.59, 95&#xa0;% CI 1.60 to 4.17, p&#xa0;&lt;&#xa0;0.001, respectively) and BAI [F vs M: OR 1.67, 95&#xa0;% CI 1.16 to 2.40, p&#xa0;=&#xa0;0.005).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">We show a substantial proportion of PACC-CO; hospitalization leads to impaired memory, anxiety and sleep disorders. Women seem to be at higher risk for anxious-depressive symptoms and worse sleep quality than men.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vergori</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Viral Immunodeficiency Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Duca</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Viral Immunodeficiency Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borrelli</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Psychology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brita</LastName><ForeName>Anna Clelia</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio" Chieti-Pescara, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinnetti</LastName><ForeName>Carmela</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Viral Immunodeficiency Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastrorosa</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Viral Immunodeficiency Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camici</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Viral Immunodeficiency Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mondi</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Viral Immunodeficiency Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzotta</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Viral Immunodeficiency Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chinello</LastName><ForeName>Pierangelo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Severe and Immune-Depression Associated Infectious Diseases Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mencarini</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giancola</LastName><ForeName>Maria Letizia</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Emerging Infectious Diseases Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdeddaim</LastName><ForeName>Amina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hepatology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girardi</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antinori</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Viral Immunodeficiency Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognitive outcomes</Keyword><Keyword MajorTopicYN="N">Long-COVID-19</Keyword><Keyword MajorTopicYN="N">Neuropsychological symptoms</Keyword><Keyword MajorTopicYN="N">Post-COVID19</Keyword><Keyword MajorTopicYN="N">Sleep disorders</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>4</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39469684</ArticleId><ArticleId IdType="pmc">PMC11513557</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2024.e39431</ArticleId><ArticleId IdType="pii">S2405-8440(24)15462-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Venkatesan Priya. NICE guideline on long COVID. Lancet Respir. Med. 2021;9(2):129. doi: 10.1016/S2213-2600(21)00031-X. 2213-2600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J. Neurol. Sci. 2022 Mar 15;434 doi: 10.1016/j.jns.2022.120162. Epub 2022 Jan 29. PMID: 35121209; PMCID: PMC8798975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Daroische R., Hemminghyth M.S., Eilertsen T.H., Breitve M.H., Chwiszczuk L.J. Cognitive impairment after COVID-19-A review on objective test data. Front. Neurol. 2021 Jul 29;12 doi: 10.3389/fneur.2021.699582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.699582</ArticleId><ArticleId IdType="pmc">PMC8357992</ArticleId><ArticleId IdType="pubmed">34393978</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipolli G.C., Alonso V., Yasuda C.L., Assump&#xe7;&#xe3;o D., Cachioni M., Melo R.C., Hinsliff-Smith K., Yassuda M.S. Cognitive impairment in post-acute COVID-19 syndrome: a scoping review. Arq Neuropsiquiatr. 2023 Dec;81(12):1053&#x2013;1069. doi: 10.1055/s-0043-1777115. Epub 2023 Dec 29. PMID: 38157873; PMCID: PMC10756850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1777115</ArticleId><ArticleId IdType="pmc">PMC10756850</ArticleId><ArticleId IdType="pubmed">38157873</ArticleId></ArticleIdList></Reference><Reference><Citation>Zifko U., Guendling K., Seet R., Kasper S. Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care. Front. Pharmacol. 2024 Apr 22;15 doi: 10.3389/fphar.2024.1338235. PMID: 38711990; PMCID: PMC11072190.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2024.1338235</ArticleId><ArticleId IdType="pmc">PMC11072190</ArticleId><ArticleId IdType="pubmed">38711990</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. A . 2021. Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus; p. 1. WHO Reference Number: WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort:7 months of symptoms and their impact. EClinicalMedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-coronavirus Disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J. Infect. Dis. 2022 Nov 1;226(9):1593&#x2013;1607. doi: 10.1093/infdis/jiac136. PMID: 35429399; PMCID: PMC9047189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., Lin K., Mansur R.B., Ho R.C., Rosenblat J.D., Miskowiak K.W., Vinberg M., Maletic V., McIntyre R.S. Fatigue and cognitive impairment in post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 2022 Mar;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020. Epub 2021 Dec 29. PMID: 34973396; PMCID: PMC8715665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, H., Lu, S., Chen, J., Wei, N., Wang, D., Lyu, H., Shi, C., Hu, S. The landscape of cognitive function in recovered COVID-19 patients J. Psychiatr 2020. Res. 129,98&#x2013;102. 10.1016/j.jpsychires.2020.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.06.022</ArticleId><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J.H., Lin J.J., Doernberg M., Stone K., Navis A., Festa J.R., Wisnivesky J.P. Assessment of cognitive function in patients after COVID-19 infection. JAMANetw. 2021;4(10) doi: 10.1001/jamanetworkopen.2021.30645. Open.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kessel S., Olde Hartman T., Lucassen P., Van Jaarsveld C. Post-acute andlong-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam.Pract. 2022:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Toniolo S., Hampshire A., Husain M. Effects of COVID-19 on cognition and brain health. Trends Cogn Sci. 2023 Nov;27(11):1053&#x2013;1067. doi: 10.1016/j.tics.2023.08.008. Epub 2023 Aug 30. PMID: 37657964; PMCID: PMC10789620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tics.2023.08.008</ArticleId><ArticleId IdType="pmc">PMC10789620</ArticleId><ArticleId IdType="pubmed">37657964</ArticleId></ArticleIdList></Reference><Reference><Citation>Julide T., Cigdem T., Baris T. Cognitive impairment in long-COVID. Ideggyogy Sz. 2024 May 30;77(5&#x2013;6):151&#x2013;159. doi: 10.18071/isz.77.0151. PMID: 38829253.</Citation><ArticleIdList><ArticleId IdType="doi">10.18071/isz.77.0151</ArticleId><ArticleId IdType="pubmed">38829253</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera E., P&#xe9;rez-S&#xe1;nchez M.d.C., San Miguel-Abella R., et al. Cognitive impairment in young adults with post COVID-19 syndrome. Sci. Rep. 2023;13:6378. doi: 10.1038/s41598-023-32939-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32939-0</ArticleId><ArticleId IdType="pmc">PMC10113715</ArticleId><ArticleId IdType="pubmed">37076533</ArticleId></ArticleIdList></Reference><Reference><Citation>Pihlaja R.E., Kauhanen L.S., Ollila H.S., Tuulio-Henriksson A.S., Koskinen S.K., Tiainen M., Salmela V.R., H&#xe4;stbacka J., Hokkanen L.S. Associations of subjective and objective cognitive functioning after COVID-19: a six-month follow-up of ICU, ward, and home-isolated patients. Brain Behav Immun Health. 2023 Jan;5 doi: 10.1016/j.bbih.2023.100587. Epub ahead of print. PMID: 36624888; PMCID: PMC9812472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100587</ArticleId><ArticleId IdType="pmc">PMC9812472</ArticleId><ArticleId IdType="pubmed">36624888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivchenko G.S., Lobzhanidze N.N., Rusina D.S., Denisova E.V., Ivchenko A.A. [Mild post-COVID syndrome in young patients] Ter. Arkh. 2023 Oct 11;95(8):674&#x2013;678. doi: 10.26442/00403660.2023.08.202349. PMID: 38158904.</Citation><ArticleIdList><ArticleId IdType="doi">10.26442/00403660.2023.08.202349</ArticleId><ArticleId IdType="pubmed">38158904</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderlind W.M., Rabinovitz B.B., Miao I.Y., Oberlin L.E., Bueno-Castellano C., Fridman C., Jaywant A., Kanellopoulos D. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Curr. Opin. Psychiatr. 2021;34(4):420&#x2013;433. doi: 10.1097/YCO.0000000000000713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YCO.0000000000000713</ArticleId><ArticleId IdType="pmc">PMC8183238</ArticleId><ArticleId IdType="pubmed">34016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Lindner A., Kofler M., Ianosi B.A., Mahlknecht P., Heim B., Peball M., Carbone F., Limmert V., Kindl P., Putnina L., Fava E., Sahanic S., Sonnweber T., L&#xf6;scher W.N., Wanschitz J.V., Zamarian L., Djamshidian A., Tancevski I., Weiss G., Bellmann-Weiler R., Kiechl S., Seppi K., Loeffler-Ragg J., Pfausler B., Helbok R. Neurological outcomes 1 year after COVID-19 diagnosis: a prospective longitudinal cohort study. Eur. J. Neurol. 2022 Jun;29(6):1685&#x2013;1696. doi: 10.1111/ene.15307. Epub 2022 Mar 23. PMID: 35239247; PMCID: PMC9111823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15307</ArticleId><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeria M., Cejudo J.C., Sotoca J., Deus J., Krupinski J. Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav. Immun. Health. 2020;9 doi: 10.1016/j.bbih.2020.100163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100163</ArticleId><ArticleId IdType="pmc">PMC7581383</ArticleId><ArticleId IdType="pubmed">33111132</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackmon K., Day G.S., Powers H.R., Bosch W., Prabhakaran D., Woolston D., Pedraza O. Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage. Res. Sq. 2022 doi: 10.21203/rs.3.rs-1127420/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1127420/v1</ArticleId><ArticleId IdType="pmc">PMC9338515</ArticleId><ArticleId IdType="pubmed">35907815</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Fugledalen L., Jespersen A.E., Sattler S.M., Podlekareva D., Rungby J., Porsberg C.M., Johnsen S. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: pattern, severity, and functional implications. Eur. Neuropsychopharmacol. 2022;59:82&#x2013;92. doi: 10.1016/j.euroneuro.2022.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2022.04.004</ArticleId><ArticleId IdType="pmc">PMC9008126</ArticleId><ArticleId IdType="pubmed">35561540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen A., Castro A.W., Ferretti M.T., Martinkova J., Vasilevskaya A., Santuccione Chadha A., Tartaglia M.C. Sex and gender differences in the neurological and neuropsychiatric symptoms of long COVID: a narrative review. Ital J sex-Specific Med. 2022;8(1):18&#x2013;28. doi: 10.1723/3769.37563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1723/3769.37563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R., Dini M., Groppo E., Rosci C., Reitano M.R., Bai F., Priori A. Long-Lasting cognitive abnormalities after COVID-19. Brain Sci. 2021;11(2):235. doi: 10.3390/brainsci11020235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11020235</ArticleId><ArticleId IdType="pmc">PMC7917789</ArticleId><ArticleId IdType="pubmed">33668456</ArticleId></ArticleIdList></Reference><Reference><Citation>Moncrieff J., Cooper R.E., Stockmann T., et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2023;28:3243&#x2013;3256. doi: 10.1038/s41380-022-01661-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01661-0</ArticleId><ArticleId IdType="pmc">PMC10618090</ArticleId><ArticleId IdType="pubmed">35854107</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Azor A., Atchison C., Trender W., Hellyer P.J., Giunchiglia V., Husain M., Cooke G.S., Cooper E., Lound A., Donnelly C.A., Chadeau-Hyam M., Ward H., Elliott P. Cognition and memory after covid-19 in a large community sample. N. Engl. J. Med. 2024 Feb 29;390(9):806&#x2013;818. doi: 10.1056/NEJMoa2311330. PMID: 38416429; PMCID: PMC7615803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2311330</ArticleId><ArticleId IdType="pmc">PMC7615803</ArticleId><ArticleId IdType="pubmed">38416429</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W.M., Alexopoulos G.S., et al. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacol. 2021;46:2235&#x2013;2240. doi: 10.1038/s41386-021-00978-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-021-00978-8</ArticleId><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard C.E., S&#xfc;tsch C., Bengs S., Deforth M., Buehler K.P., Hamouda N., et al. Sex- and gender-specific risk factors of post-COVID-19 syndrome: a population-based cohort study in Switzerland. medRxiv. 2021;06.30</Citation></Reference><Reference><Citation>Guill&#xe9;n N., P&#xe9;rez-Millan A., Falg&#xe0;s N., Lled&#xf3;-Ib&#xe1;&#xf1;ez G.M., Rami L., Sarto J., Bot&#xed; M.A., Arnaldos-P&#xe9;rez C., Ruiz-Garc&#xed;a R., Naranjo L., Segura B., Balasa M., Sala-Llonch R., Llad&#xf3; A., Gray S.M., Johannesen J.K., Pantoni M.M., Rutledge G.A., Sawant R., Wang Y., Watson L.S., Dalmau J., Sanchez-Valle R. Cognitive profile, neuroimaging and fluid biomarkers in post-acute COVID-19 syndrome. Sci. Rep. 2024 Jun 5;14(1) doi: 10.1038/s41598-024-63071-2. PMID: 38839833; PMCID: PMC11153491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-63071-2</ArticleId><ArticleId IdType="pmc">PMC11153491</ArticleId><ArticleId IdType="pubmed">38839833</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen A., Castro A.W., Ferretti M.T., Martinkova J., Vasilevskaya A., Santuccione Chadha A., Tartaglia M.C. Sex and gender differences in the neurological and neuropsychiatric symptoms of long COVID: a narrative review. Ital J Gender-Specific Med. 2022;8(1):18&#x2013;28. doi: 10.1723/3769.37563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1723/3769.37563</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>